Chiesi Ventures

Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Our goal is to complement the strategic interest of the Chiesi Group by investing in early-stage development opportunities. Chiesi Ventures also aims to accelerate the expansion of the Chiesi network in the EU and the US among universities, venture capital investors, rare disease patient organizations, and entrepreneurial companies developing treatments for rare diseases. Investment Focus We believe that one day every rare disease will be diagnosed rapidly and will have a cure, no matter how many rare diseases there are. Chiesi Ventures focuses on creating a better world by investing in promising start-ups that provide services and treatments for rare diseases. TRADITIONAL SMALL MOLECULES AND BIOLOGICS We like exploring the development of new chemical entities and new biological entities for specific therapeutic challenges. ADVANCED THERAPIES We support highly innovative gene therapies and stem cell therapies. REFORMULATION TECHNOLOGIES AND DEVICES We shun away from simple generics or marginally improved therapeutics. We like innovative, smart reformulations of known compounds that create great value for patients. DISEASE DISCOVERY, DIAGNOSIS, AND MANAGEMENT We invest in tools and services that help society in its journey through the discovery of rare diseases, the improvement of their diagnosis, and management.